Neurokinin 1 substance P (TAC1; NK1); NK1 substance P receptor (TACR1); HER2 (EGFR2; ErbB2; neu) BriefCommunication Pages: 1121 - 1121
Retinoic acid receptor responder (tazarotene induced) 1 (RARRES1; TIG1); AXL receptor tyrosine kinase (AXL; UFO) BriefCommunication Pages: 1122 - 1122
MHC class I polypeptide–related sequence B (MICB); killer cell lectin-like receptor subfamily K member 1 (KLRK1; CD314; NKG2D) BriefCommunication Pages: 1123 - 1123
Hypoxia-inducible factor prolyl hydroxylase 3 (EGLN3; HIF-PH3; PHD3) BriefCommunication Pages: 1126 - 1126
Solute carrier family 30 zinc transporter member 8 (SLC30A8; ZNT8) BriefCommunication Pages: 1128 - 1128
In vitro generation of branched polyketides using bacterial polyketide synthase (PKS) BriefCommunication Pages: 1140 - 1140
Photoreceptors differentiated from patient keratinocyte–derived induced pluripotent stem (iPS) cells to model ophthalmic diseases BriefCommunication Pages: 1141 - 1141
Matrix metalloproteinase 2 (MMP2)-activated, chemotherapeutic nanocarriers for targeted drug delivery BriefCommunication Pages: 1142 - 1142
Tumor-specific delivery of chemotherapy using micelles with phenylboronic acid on their surface (PBA-micelles) BriefCommunication Pages: 1143 - 1143
Inhibition of methyl-CpG binding domain protein 3 (MBD3) for deterministic and synchronized reprogramming to pluripotency BriefCommunication Pages: 1144 - 1144
Stabilizing, camelid-derived nanobodies to facilitate generation of crystal structures of GPCRs bound to low-affinity, natural ligands BriefCommunication Pages: 1145 - 1145
Synthesis of therapeutic peptides resistant to degradation by serine proteases BriefCommunication Pages: 1146 - 1146
Microtubule-associated protein-τ (MAPT; TAU; FTDP-17)-staining PET reagent for imaging Alzheimer's disease (AD) pathology BriefCommunication Pages: 1147 - 1147
Kaposi sarcoma–associated herpes virus (KSHV; HHV-8) as a biomarker for castration-resistant prostate cancer (CRPC) BriefCommunication Pages: 1149 - 1149